AIM: The aim of the present study was to determine the percentage of recession coverage achieved following surgery with a collagen matrix, and @entity1 -reported outcome measures. METHODS: Five healthy adults who had completed orthodontic therapy with a @entity1464 defect were recruited. @entity1464 coverage was performed using a two-layer, xenogeneic collagen matrix (Mucograft). During the first 2  weeks, the @entity1 charted their perceptions on @entity548 ,  swelling, @entity158 , and @entity2981 using a visual analog scale (VAS). @entity532 were assessed clinically at 1  week, 2  weeks, and 1  month post-surgery. Recession dimensions were examined at 1, 3, 6, and 12  months. RESULTS: At 1  year, an average of 67% root coverage was achieved. The amount of recession coverage achieved was stable from 3  months. The results were maintained at 1  year. There were no post-surgical complications. All VAS parameters decreased to almost zero by day 14. From day 1, @entity548 and @entity158 decreased over time. However, there were peaks on days 2 and 3 for swelling and @entity2981 , respectively, followed by a subsequent decrease. CONCLUSIONS: The use of Mucograft for recession coverage is effective and safe, with low morbidity and no post-surgical complications. Recession coverage achieved at 3  months remained stable in the 1-year follow-up period.

Use of a collagen matrix for recession coverage in XXXX who received orthodontic therapy: a case series.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1464 :: ('MESH:D005889', 'Disease') :: ['gingival recession', 'Gingival recession'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity532 :: ('MESH:D003925', 'Disease') :: ['Post-surgical complications'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity2981 :: ('MESH:D003288', 'Disease') :: ['bruising']
@entity1 :: (9606,Species) :: ['patients']
